Non‐invasive fibrosis biomarkers – <scp>APRI</scp> and <scp>F</scp>orns – are associated with liver stiffness in <scp>HIV</scp>‐monoinfected patients receiving antiretroviral drugs

Hamid Hasson(Vita-Salute San Raffaele University), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Emanuela Messina(Vita-Salute San Raffaele University), Antonella Castagna(Vita-Salute San Raffaele University), Stefania Salpietro(IRCCS Ospedale San Raffaele), Sabrina Bagaglio(Vita-Salute San Raffaele University), Marco Merli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Giulia Morsica(Vita-Salute San Raffaele University), Alessia Carbone(IRCCS Ospedale San Raffaele), Laura Galli(Vita-Salute San Raffaele University), Giulia Gallotta(Vita-Salute San Raffaele University)
Liver International
March 12, 2013
10.1111/liv.12159
Cited by 11

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362